Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.
about
Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Non-selective beta blockers in ...... with metastatic angiosarcoma.
@en
Non-selective beta blockers in ...... with metastatic angiosarcoma.
@nl
type
label
Non-selective beta blockers in ...... with metastatic angiosarcoma.
@en
Non-selective beta blockers in ...... with metastatic angiosarcoma.
@nl
prefLabel
Non-selective beta blockers in ...... with metastatic angiosarcoma.
@en
Non-selective beta blockers in ...... with metastatic angiosarcoma.
@nl
P2093
P2860
P356
P1433
P1476
Non-selective beta blockers in ...... with metastatic angiosarcoma.
@en
P2093
Alejandro Vargas
Alexa Montoya
Alexandria Rivas
Andres Belmont
Arezo Nasrazadani
Brad A Bryan
Christopher Lopez
Clarissa N Amaya
Connie Herrera
Dana Galvan
P2860
P304
P356
10.18632/ONCOSCIENCE.413
P577
2018-03-01T00:00:00Z